CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

HealthBeacon plans Euronext market debut on €25m fund raise

By Adrian Holliday

10:35, 10 December 2021

Syringe and meds laid on a glass table
Dublin-based meditech firm confirms plans of listing on on Euronext Growth Market – Photo: Shutterstock

Irish digital medical technology firm HealthBeacon announced today its intention to trade on the Euronext Growth Market from next Wednesday.

The float price will be €5.85 per ordinary share and more than 4.27 million shares will be issued.  

All in, the fully diluted market capitalisation values HealthBeacon at €100m.

HealthBeacon says the initial public offering (IPO), supported by a €25m investor funding round including venture capital investor Bill McCabe, should be effective from 8 in the morning of 15 December.

Self-administer sales targets in place 

HealthBeacon says its aim is to make its products accessible to people managing at-home injectable medications. The IPO is part-designed to support the acceleration of the company’s growth strategy, scaling sales and marketing and ongoing tech development.


1,991.87 Price
-0.690% 1D Chg, %
Long position overnight fee -0.0199%
Short position overnight fee 0.0117%
Overnight fee time 22:00 (UTC)
Spread 0.50


0.62 Price
-6.410% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168


41,917.20 Price
-4.360% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00


16,065.40 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Robert Garber, independent non-executive chairman of HealthBeacon said the Dublin listing “is a game-changer for the business, enabling it to further scale its unique product for its customers”.

“The proceeds raised through this IPO,” adds CEO and co-founder Jim Joyce, “will enable us to scale to meet potential demand, as we anticipate a ten-fold increase in the number of patients using our injection care management system by the end of 2023.” 

“As we embark on our next chapter as a public company, we are excited about the potential of our target market and the proven ability for our product to meaningfully increase medical adherence for patients in a safe and sustainable way.”

HealthBeacon, founded in 2013, is thought to have further design and utility patents in place.

Read more: Stock markets in Australia, Japan and Hong Kong fall

Rate this article

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading